Peripheral administration of hypothalamic peptides results in CNS changes.
D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D004745:Enkephalins / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006801:Humans; D007031:Hypothalamus; D009075:MSH Release-Inhibiting Hormone / Q000494:pharmacology; D010907:Pituitary Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D013004:Somatostatin / Q000494:pharmacology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D004745:Enkephalins; D010907:Pituitary Hormones; D007987:Gonadotropin-Releasing Hormone; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D009075:MSH Release-Inhibiting Hormone